Key facts
- This page summarizes Stuart Naylor's Form 4 filing for MeiraGTx Holdings plc (MGTX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 29 Jun 2026, 21:17.
Stuart Naylor - 25 Jun 2026 Form 4 Insider Report for MeiraGTx Holdings plc (MGTX)
- Reporting relationship
- CHIEF SCI OFCR, OPHTHALMOLOGY
- Issuer ticker
- MGTX
- Reported as of
- 25 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Jun 2026, 21:17:46 UTC
- Prior SEC filing
- 07 Apr 2026
- Next SEC filing
- 07 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard Giroux, Attorney-in-Fact for Stuart Naylor
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stuart Naylor filed Form 4 for MeiraGTx Holdings plc (MGTX) on 29 Jun 2026.
Change
- Previous filing in this sequence was filed on 07 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001742771
Primary reporting owner
Naylor Stuart
- Relationship
- CHIEF SCI OFCR, OPHTHALMOLOGY
- Address
- 655 THIRD AVENUE, SUITE 1115, NEW YORK
- Signature
- /s/ Richard Giroux, Attorney-in-Fact for Stuart Naylor
- Signature date
- 29 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MGTX
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- Shares
- +70,000
- Change %
- Price
- $0.000000*
- Shares after
- 70,000
- Date
- 25 Jun 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 70,000
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted share unit converts into one ordinary share upon vesting.
Footnote F2
Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.